Trexquant Investment LP Has $18.40 Million Stock Position in Envista Holdings Corporation $NVST

Key Points

• Trexquant Investment LP has significantly increased its holdings in Envista Holdings by 243.7%, owning about 1,065,849 shares valued at approximately $18.40 million.
• Various hedge funds have also increased their stakes in Envista, with GAMMA Investing LLC raising their holdings by a staggering 1,338.3% during the first quarter.
• Analysts have revised the price targets for Envista, with Baird R W upgrading it to a "strong-buy" rating and setting a target price of $23.00, while the consensus rating remains at "Hold" with a target price of $20.92.

Trexquant Investment LP raised its position in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) by 243.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,065,849 shares of the company's stock after purchasing an additional 755,725 shares during the period. Trexquant Investment LP owned approximately 0.63% of Envista worth $18,397,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of NVST. Tower Research Capital LLC TRC grew its stake in shares of Envista by 51.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company's stock worth $213,000 after buying an additional 3,751 shares during the last quarter. Northern Trust Corp grew its stake in shares of Envista by 21.2% during the fourth quarter. Northern Trust Corp now owns 1,751,643 shares of the company's stock worth $33,789,000 after buying an additional 306,019 shares during the last quarter. Comerica Bank grew its stake in shares of Envista by 8.2% during the fourth quarter. Comerica Bank now owns 121,851 shares of the company's stock worth $2,350,000 after buying an additional 9,248 shares during the last quarter. Ariel Investments LLC grew its stake in shares of Envista by 6.2% during the fourth quarter. Ariel Investments LLC now owns 12,059,624 shares of the company's stock worth $232,630,000 after buying an additional 699,625 shares during the last quarter. Finally, ArrowMark Colorado Holdings LLC grew its stake in shares of Envista by 125.8% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 521,643 shares of the company's stock worth $10,062,000 after buying an additional 290,643 shares during the last quarter.

Envista Trading Down 0.5%

NVST traded down $0.11 during trading on Friday, reaching $21.15. 1,038,714 shares of the stock traded hands, compared to its average volume of 1,878,506. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $3.51 billion, a PE ratio of 66.08, a P/E/G ratio of 1.13 and a beta of 0.99. The stock's 50-day moving average is $20.29 and its 200 day moving average is $18.58. Envista Holdings Corporation has a 12 month low of $14.22 and a 12 month high of $23.00.

Envista (NYSE:NVST - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. The business had revenue of $682.10 million for the quarter, compared to analysts' expectations of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. The business's quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.11 earnings per share. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. Equities analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on NVST. Mizuho boosted their target price on shares of Envista from $15.00 to $18.00 and gave the stock an "underperform" rating in a research note on Friday, August 1st. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Wells Fargo & Company boosted their price objective on shares of Envista from $17.00 to $19.00 and gave the stock an "equal weight" rating in a research note on Friday, August 1st. Stifel Nicolaus boosted their price objective on shares of Envista from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Finally, Evercore ISI boosted their price objective on shares of Envista from $19.00 to $23.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 9th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $20.92.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.